3677Jiangsu Zenergy Battery Technologies Group Co., Ltd.

🇭🇰 Hong Kong Borsası
3.60
HKD
Analysis Scores
Lothien Robustness Score?
70/100
Strong
Neden bu skor?
Damodaran ?
55/100
Dalio Risk ?
64/100
Piotroski ?
7/9
Strong
Graham ?
HK$5.6
Ucuz
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
64/100
Lothien Sağlamlık: Güçlü (64/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Nötr | Uzun Vade: Nötr | Pozitif: 5 | Negatif: 2 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte HK$238M net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+0.0). İstikrarlı seyir.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+788.4 arttı. Büyüme trendi sağlıklı.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+57.9 arttı. Şirket büyüyor.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif (HK$238M) ama FCF negatif (-HK$342M). Yatırım harcamaları yüksek veya alacak birikimi var.
Makul F/K
Trailing F/K: 9.7. Makul değerleme aralığında.
Defter Değerinin Altında
PD/DD: 0.97. Hisse defter değerinin altında işlem görüyor. Değer tuzağı mı yoksa fırsat mı iyi analiz edilmeli.
Düşük ROE
ROE: %5.0. Sermaye getirisi yetersiz — enflasyonun altında.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+26.8 artabilir (HK$238M → HK$301M).

Data date 2026-10-23 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-23
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Yüksek
252 days
Annual Volatility ?
%43.6
VaR 95% ?
%4.95
daily max loss
VaR 99% ?
%6.83
daily max loss
CVaR 95% ?
%6.39
expected loss (tail)
Max Drawdown ?
%70.9
16.10.2025 → 22.10.2026
Skewness ?
0.18
Parametrik%4.95
Historik%4.27
Cornish-Fisher%4.65
Return Distribution
Valuation
Potential?
+34.7%
ROIC ?
4.5%
DCF Value ?
6.21
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/6
Son 6 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-14.3 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 4.20 HKD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %10.0
Net profit margin %10.0 — positive but low. Compared to previous quarter +0.0 point increase.
ROE - Return on Equity (TTM) %5.0
ROE %5.0 — low return on equity.
EBITDA Margin %18.5
EBITDA margin %18.5 — good operational performance.
Gross Profit Margin %18.4
Gross profit per revenue %18.4. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-14.4
TTM Free Cash Flow is %-14.4'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 9.7x Sector: 12.3x
F/K 9.7x — sector median (12.3x) near reasonable levels.
P/B Ratio 0.97x Sector: 1.54x
PD/DD 0.97x — sector median's (1.54x) well below. Cheap relative to book value.
EV/EBITDA 6.3x Sector: 7.6x
EV/EBITDA 6.3x — sector median (7.6x) in line.
Indebtedness
Current Ratio 1.03x
Current ratio 1.03x — borderline, attention required.
Net Debt / EBITDA 3.9x
Net Debt/EBITDA 3.9x — high debt burden. Debt service creating pressure.
Debt / Equity 0.72x
Debt/Equity 0.72x — moderate financial leverage.
Interest Coverage 6.5x
Interest coverage 6.5x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY) %+57.9
Revenue YoY %57.9 grew (2025/12) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+788.4
Net profit YoY %788.4 increased (2025/12) — extraordinary profit growth.
Score Explanations
Lothien Robustness
70/100
Good robustness (70/100). The company shows a generally balanced financial profile; some areas have room for improvement.
Strong
Potential
+34.7%
Plus %34.7 expected value (4.85) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 4.88 | P/B target: 5.90 | EV/EBITDA target: 4.32 | DCF target: 6.21
Damodaran Valuation
55/100
Moderate Damodaran score (55/100). ROIC (%4.5) – WACC (%7.9) difference -3.4 bps. Value creation capacity limited.
Moderate
Dalio Risk Analysis
64/100
Moderate debt risk (64/100). Interest coverage ratio 6.5x — strong. Debt/EBITDA 3.9x — manageable.
Leverage: 67/100 | Debt Service: 76/100 | Quality: 68/100
ROIC - Return on Capital
%4.5
ROIC (%4.5) cost of capital (7.9%) below → destroying value.
WACC: %7.9
DCF Discounted Cash Flow
6.21
DCF modeli 6.21 target value produced — compared to current price %72.6 undervalued.
Current price: 3.60
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
7/9
Strong Piotroski F-Score (7/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
HK$5.6
Graham intrinsic value: HK$5.6. Ucuz
Cheap
⚖️ Sector Comparison
P/E Ratio
9.7x vs 12.3x
Sector median's %21 below — cheap
P/B Ratio
0.97x vs 1.54x
Compared to sector %37 cheaper (by book value)
EV/EBITDA
6.3x vs 7.6x
Compared to sector %17 lower EV/EBITDA
ROIC vs WACC
%4.5 vs %7.9 WACC
ROIC 3.4 bps below cost of capital
Net Profit Margin (TTM)
%10.0 vs %18.5 EBITDA margin
TTM net profit margin %10.0
TRAMA-99 Trend — Downtrend
Price (3.60), TRAMA-99 line's %14.3 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 3.60
TRAMA: 4.20
Difference: %-14.3
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
P/E Ratio ?
P/B Ratio ?
EBITDA ?
Net Working Capital ?
Current Ratio ?
3677 — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.